|
1
|
Glaziou P, Falzon D, Floyd K and
Raviglione M: Global epidemiology of tuberculosis. Semin Respir
Crit Care Med. 34:3–16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shih TY, Young TH, Lee HS, Hsieh CB and Hu
OY: Protective effects of kaempferol on isoniazid- and
rifampicin-induced hepatotoxicity. AAPS J. 15:753–762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi Q, Hong H, Senior J and Tong W:
Biomarkers for drug-induced liver injury. Expert Rev Gastroenterol
Hepatol. 4:225–234. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zelber-Sagi S, Toker S, Armon G, Melamed
S, Berliner S, Shapira I, Halpern Z, Santo E and Shibolet O:
Elevated alanine aminotransferase independently predicts new onset
of depression in employees undergoing health screening
examinations. Psychol Med. 43:2603–2613. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang X, Greenhaw J, Shi Q, Su Z, Qian F,
Davis K, Mendrick DL and Salminen WF: Identification of urinary
microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol
Sci. 125:335–344. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Sun S, Shen L, Zu X, Chen Y, Hao
J, Huang X and Feng F: DNA methylation in the rat livers induced by
low dosage isoniazid treatment. Environ Toxicol Pharmacol.
32:486–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duskova K, Nagilla P, Le HS, Iyer P,
Thalamuthu A, Martinson J, Bar-Joseph Z, Buchanan W, Rinaldo C and
Ayyavoo V: MicroRNA regulation and its effects on cellular
transcriptome in human immunodeficiency virus-1 (HIV-1) infected
individuals with distinct viral load and CD4 cell counts. BMC
Infect Dis. 3:2502013. View Article : Google Scholar
|
|
8
|
Mi SL, Zhang J, Zhang W and Huang RS:
Circulating microRNAs as biomarkers for inflammatory diseases.
Microrna. 2:64–72. 2013. View Article : Google Scholar
|
|
9
|
Henderson MC and Azorsa DO: The genomic
and proteomic content of cancer cell-derived exosomes. Front Oncol.
2:382012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu D and Murashov AK: Molecular mechanisms
of peripheral nerve regeneration: Emerging roles of microRNAs.
Front. 4:552013.
|
|
12
|
Ulivi P, Foschi G, Mengozzi M, Scarpi E,
Silvestrini R, Amadori D and Zoli W: Peripheral blood miR-328
expression as a potential biomarker for the early diagnosis of
NSCLC. Int J Mol Sci. 14:10332–10342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sita-Lumsden A, Dart DA, Waxman J and
Bevan CL: Circulating microRNAs as potential new biomarkers for
prostate cancer. Br J Cancer. 108:1925–1930. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giusti I, D'Ascenzo S and Dolo V:
Microvesicles as potential ovarian cancer biomarkers. BioMed Res
Int. 2013:7030482013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang B, Wang H and Yang Z: MiR-122
inhibits cell proliferation and tumorigenesis of breast cancer by
targeting IGF1R. PLoS One. 7:e470532012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ,
Shen R, Huang Y, Chen HC, Lee CH, Tsai TF, et al: MicroRNA-122
plays a critical role in liver homeostasis and
hepatocarcinogenesis. J Clin Invest. 22:2884–2897. 2012. View Article : Google Scholar
|
|
17
|
Arataki K, Hayes CN, Akamatsu S, Akiyama
R, Abe H, Tsuge M, Miki D, Ochi H, Hiraga N, Imamura M, et al:
Circulating microRNA-22 correlates with microRNA-122 and represents
viral replication and liver injury in patients with chronic
hepatitis B. J Med Virol. 85:789–798. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Antoine DJ, Dear JW, Lewis PS, Platt V,
Coyle J, Masson M, Thanacoody RH, Gray AJ, Webb DJ, Moggs JG, et
al: Mechanistic biomarkers provide early and sensitive detection of
acetaminophen-induced acute liver injury at first presentation to
hospital. Hepatology. 58:777–787. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Jia Y, Zheng R, Guo Y, Wang Y,
Guo H, Fei M and Sun S: Plasma microRNA-122 as a biomarker for
viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem.
56:1830–1838. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lind EF and Ohashi PS: Mir-155, a central
modulator of T-cell responses. Eur J Immunol. 44:11–15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
McDaniel K, Herrera L, Zhou T, Francis H,
Han Y, Levine P, Lin E, Glaser S, Alpini G and Meng F: The
functional role of microRNAs in alcoholic liver injury. J Cell Mol
Med. 18:197–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei Y, Nazari-Jahantigh M, Neth P, Weber C
and Schober A: MicroRNA-126, −145, and −155: A therapeutic triad in
atherosclerosis? Arterioscler Thromb Vasc Biol. 33:449–454. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Farooqi AA, Qureshi MZ, Coskunpinar E,
Naqvi SK, Yaylim I and Ismail M: miR-421, miR-155 and miR-650:
Emerging trends of regulation of cancer and apoptosis. Asian Pac J
Cancer Prev. 15:1909–1912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang B, Majumder S, Nuovo G, Kutay H,
Volinia S, Patel T, Schmittgen TD, Croce C, Ghoshal K and Jacob ST:
Role of microRNA-155 at early stages of hepatocarcinogenesis
induced by choline-deficient and amino acid-defined diet in C57BL/6
mice. Hepatology. 50:1152–1161. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pogribny IP, Starlard-Davenport A,
Tryndyak VP, Han T, Ross SA, Rusyn I and Beland FA: Difference in
expression of hepatic microRNAs miR-29c, miR-34a, miR-155, asnd
miR-200b is associated with strain-specific susceptibility to
dietary nonalcoholic steatohepatitis in mice. Lab Invest.
90:1437–1446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan TM, Liu DC, Wang JF, Cai S, Lin MJ,
Lu RR, Wu KF, Ma XL, Wu T and Li WD: Protective effect of extract
from fruit of Clausena lansium (Lour.) Skeels against acute
alcohol-induced hepatotoxicity in mice. Zhong Guo Yao Li Xue Yu Du
Li Xue Za Zhi. 26:829–834. 2012.(In Chinese).
|
|
28
|
Le HS and Bar-Joseph Z: Integrating
sequence, expression and interaction data to determine
condition-specific miRNA regulation. Bioinformatics. 29:i89–i97.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hou YN, Zhang XL and Wu HH: Effect of
rifampicin and isoniazid coadministration on the metabolism and
pharmacokinetics of isoniazid in mice. Jie Fang Jun Yao Xue Xue
Bao. 27:23–26. 2011.(In Chinese).
|
|
30
|
Wang K, Zhang S, Marzolf B, Troisch P,
Brightman A, Hu Z, Hood LE and Galas DJ: Circulating microRNAs,
potential biomarkers for drug-induced liver injury. Proc Natl Acad
Sci USA. 106:4402–4407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ceppi M, Pereira PM, Dunand-Sauthier I,
Barras E, Reith W, Santos MA and Pierre P: MicroRNA-155 modulates
the interleukin-1 signaling pathway in activated human
monocyte-derived dendritic cells. Proc Natl Acad Sci USA.
106:2735–2740. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu F, Weidmer A, Liu CG, Volinia S, Croce
CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates
NF-kappaB signaling and stabilizes latent virus persistence. J
Virol. 82:10436–10443. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuo YC, Li YS, Zhou J, Shih YR, Miller M,
Broide D, Lee OK and Chien S: Human mesenchymal stem cells suppress
the stretch-induced inflammatory miR-155 and cytokines in bronchial
epithelial cells. PLoS One. 8:e713422013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nazari-Jahantigh M, Wei Y, Noels H, Akhtar
S, Zhou Z, Koenen RR, Heyll K, Gremse F, Kiessling F, Grommes J, et
al: MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in
macrophages. J Clin Invest. 122:4190–4202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tili E, Michaille JJ, Cimino A, Costinean
S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA and
Croce CM: Modulation of miR-155 and miR-125b levels following
lipopolysaccharide/TNF-alpha stimulation and their possible roles
in regulating the response to endotoxin shock. J Immunol.
179:5082–5089. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Miller AM, Gilchrist DS, Nijjar J, Araldi
E, Ramirez CM, Lavery CA, Fernández-Hernando C, McInnes IB and
Kurowska-Stolarska M: MiR-155 has a protective role in the
development of non-alcoholic hepatosteatosis in mice. PLoS One.
8:e723242013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Senior JR: Alanine aminotransferase: A
clinical and regulatory tool for detecting liver injury-past,
present, and future. Clin Pharmacol Ther. 92:332–339. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yamaura Y, Nakajima M, Takagi S, Fukami T,
Tsuneyama K and Yokoi T: Plasma microRNA profiles in rat models of
hepatocellular injury, cholestasis, and steatosis. PLoS One.
7:e302502012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
An FM, Yu DS, Xie Q, Gong BD, Wang H, Guo
Q and Yu H: The role of miR-122 expression during the acute liver
failure in mice induced by D-GalN/LPS. Zhonghua Gan Zang Bing Za
Zhi. 18:527–532. 2010.(In Chinese). PubMed/NCBI
|
|
40
|
Jopling C: Liver-specific microRNA-122:
Biogenesis and function. RNA Biol. 9:137–142. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wagner AE, Boesch-Saadatmandi C, Dose J,
Schultheiss G and Rimbach G: Anti-inflammatory potential of
allyl-isothiocyanate - role of Nrf2, NF-(k) B and microRNA-155. J
Cell Mol Med. 16:836–843. 2012. View Article : Google Scholar : PubMed/NCBI
|
